Abstract:Background: The biological diagnosis criteria of the Alzheimer's disease (AD) suggests that previous work may misclassify the cognitive impairment caused by other factors into AD. Consequently, re-assessing the imaging profile of AD continuum is needed. Considering the high vulnerability of cortical association fibers, we aimed to elucidate the cortical demyelination process in the AD continuum biologically defined. Methods: According to the biological diagnosis criteria, we determined the positive amyloid status (A+) as cerebrospinal fluid (CSF) amyloid(1-42) < 192 pg/ml, Florbetapir Positron emission tomography (PET) composite standardized uptake value ratio (SUVR) > 1.11. Also, the positive Tau status (T+) was determined as p-Tau(181) > 23 pg/ml. Based on the cognitive characterization, we further categorized 252 subjects into 27 cognitively unimpaired with normal AD biomarkers (A-T-, controls), 49 preclinical AD (A+T+), 113 AD with mild cognitive impairment (MCI) (A+T+), and 63 AD dementia (A+T+). We estimated the intracortical myelin content used the T1- and T2-weighted (T1W/T2W) ratio mapping. To investigate the sensitivity of the ratio mapping, we also utilized well-validated AD imaging biomarkers as the reference, including gray matter volume and Fludeoxyglucose PET (FDG-PET). Based on the general linear model, we conducted the voxel-wise two-sample T-tests between the controls and each group in the AD continuum. Results: Compared to the controls, the results showed that the preclinical AD patients exhibited decreased T1W/T2W ratio value in the right inferior parietal lobule (IPL); as the disease progresses, the prodromal AD patients demonstrated lower ratio value in bilateral IPL, with hippocampus (HP) atrophy. Lastly, the AD dementia patients exhibited decreased ratio value in bilateral IPL and hippocampus; also, we observed the bilateral temporal cortices atrophy and widespread decreased metabolism in the AD dementia patients. After corrected with gray volume, the results remained mostly unchanged. Conclusion: Our study implied the decreased right IPL T1W/T2W ratio might represent early AD-related demyelination in disease continuum. Additionally, we demonstrated that the T1W/T2W ratio mapping is an easy-to-implement and sensitive metric to assess the intracortical myelin content in AD, particularly in the early stage.

A Study of Alzheimer’s Disease Based on DTI Gaussian Mixture Analysis

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

Characterization of Local White Matter Microstructural Alterations in Alzheimer’s Disease: A Reproducible Study

A Gaussian Mixture Model Based Diagnosis of Alzheimer's Using Diffusion Tensor Imaging

The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease

MR Diffusion Tensor Imaging (DTI) and Neuropsychological Testing for Neuronal Connectivity in Alzheimer's Disease (AD) Patients

A Study Of Data Fusion For Alzheimer'S Disease Based On Diffusion Magnetic Resonance Imaging

Diffusion tensor imaging (DTI) Analysis Based on Tract-based spatial statistics (TBSS) and Classification Using Multi-Metric in Alzheimer's Disease

Discriminative Analysis of Early-Stage Alzheimer’s Disease and Normal Aging with Automatic Segmentation Technique in Subcortical Gray Matter Structures: a Multicenter in Vivo MRI Volumetric and DTI Study

Diffusion Tensor Imaging Correlates with Proton Magnetic Resonance Spectroscopy in Posterior Cingulate Region of Patients with Alzheimer’s Disease

Discriminative Analysis of Multivariate Features from Structural MRI and Diffusion Tensor Images.

Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum

Application of Diffusion Tensor Imaging Based on Automatic Fiber Quantification in Alzheimer's Disease

DTI tract-based analysis in patients with Alzheimer’s disease

MR Diffusion Tensor Imaging-Based White Matter Studies in Mild Cognitive Impairment and Alzheimer Disease

Non-Gaussian diffusion alterations on diffusion kurtosis imaging in patients with early Alzheimer’s disease

Individual Identification Using Multi-Metric of DTI in Alzheimer's Disease and Mild Cognitive Impairment

Automated Detection of Pathologic White Matter Alterations in Alzheimer's Disease Using Combined Diffusivity and Kurtosis Method

A Novel Diffusion Tensor Image Analysis along the Perivascular Space Method to Evaluate Glymphatic Alterations in Alzheimer’s Disease

[P2–377]: MULTI‐MODAL EVALUATION OF ALZHEIMER's DISEASE BY USING JOINT ICA ANALYSIS OF FMRI‐DTI

Comparison of Diffusion Tensor Imaging and Proton MR Spectroscopy in the Posterior Cingulate of Patients with Alzheimer Disease